MR编号 | SE/H/1342/004 |
---|---|
药品名称 | Hidrasec |
活性成分 |
|
剂型 | Oral suspension |
上市许可持有人 | Bioprojet Europe Limited, Ireland |
参考成员国 - 产品名称 | Sweden (SE) |
互认成员国 - 产品名称 |
|
许可日期 | 2024/05/10 |
最近更新日期 | 2024/05/13 |
药物ATC编码 |
|
申请类型 |
|
附件文件下载 | |
市场状态 | Withdrawn(注:已撤市) 撤市原因:2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |